12-57796359-G-C

Variant summary

Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_005726.6(TSFM):​c.754G>C​(p.Val252Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000689 in 1,451,856 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 17/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V252I) has been classified as Likely benign.

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 6.9e-7 ( 0 hom. )

Consequence

TSFM
NM_005726.6 missense

Scores

19

Clinical Significance

Uncertain significance no assertion criteria provided U:1

Conservation

PhyloP100: -0.331

Publications

0 publications found
Variant links:
Genes affected
TSFM (HGNC:12367): (Ts translation elongation factor, mitochondrial) This gene encodes a mitochondrial translation elongation factor. The encoded protein is an enzyme that catalyzes the exchange of guanine nucleotides on the translation elongation factor Tu during the elongation step of mitchondrial protein translation. Mutations in this gene are associated with combined oxidative phosphorylation deficiency-3 syndrome. Alternate splicing results in multiple transcript variants.[provided by RefSeq, Mar 2010]
TSFM Gene-Disease associations (from GenCC):
  • fatal mitochondrial disease due to combined oxidative phosphorylation defect type 3
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae)
  • Leigh syndrome
    Inheritance: AR Classification: MODERATE Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.07745996).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TSFMNM_005726.6 linkc.754G>C p.Val252Leu missense_variant Exon 6 of 6 ENST00000652027.2 NP_005717.3 P43897-1E5KS95
TSFMNM_001172696.2 linkc.817G>C p.Val273Leu missense_variant Exon 7 of 7 NP_001166167.1 P43897-2
TSFMNM_001172695.2 linkc.*162G>C 3_prime_UTR_variant Exon 5 of 5 NP_001166166.1 P43897-3
TSFMNM_001172697.2 linkc.571+3286G>C intron_variant Intron 5 of 5 NP_001166168.1 P43897-4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TSFMENST00000652027.2 linkc.754G>C p.Val252Leu missense_variant Exon 6 of 6 NM_005726.6 ENSP00000499171.2 P43897-1

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
AF:
6.89e-7
AC:
1
AN:
1451856
Hom.:
0
Cov.:
31
AF XY:
0.00
AC XY:
0
AN XY:
721300
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.00
AC:
0
AN:
33336
American (AMR)
AF:
0.00
AC:
0
AN:
42774
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25830
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39414
South Asian (SAS)
AF:
0.00
AC:
0
AN:
84718
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52814
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5760
European-Non Finnish (NFE)
AF:
9.03e-7
AC:
1
AN:
1107144
Other (OTH)
AF:
0.00
AC:
0
AN:
60066
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.375
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome
Cov.:
32

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: no assertion criteria provided
LINK: link

Submissions by phenotype

Fatal mitochondrial disease due to combined oxidative phosphorylation defect type 3 Uncertain:1
Mar 21, 2025
Natera, Inc.
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.080
BayesDel_addAF
Benign
-0.26
T
BayesDel_noAF
Benign
-0.62
CADD
Benign
0.012
DANN
Benign
0.68
DEOGEN2
Benign
0.070
T;.
Eigen
Benign
-1.9
Eigen_PC
Benign
-1.8
FATHMM_MKL
Benign
0.019
N
LIST_S2
Benign
0.53
T;T
M_CAP
Benign
0.016
T
MetaRNN
Benign
0.077
T;T
MetaSVM
Benign
-0.94
T
MutationAssessor
Benign
-1.4
N;.
PhyloP100
-0.33
PrimateAI
Benign
0.27
T
PROVEAN
Benign
0.82
N;N
REVEL
Benign
0.12
Sift
Benign
0.99
T;T
Sift4G
Benign
1.0
T;T
Polyphen
0.0
B;B
Vest4
0.14
MutPred
0.60
Gain of helix (P = 0.0496);.;
MVP
0.71
MPC
0.054
ClinPred
0.060
T
GERP RS
-1.9
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.016
gMVP
0.33
Mutation Taster
=98/2
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs114694283; hg19: chr12-58190142; API